Update on nasal polyps: Etiopathogenesis

Journal of the Medical Association of Thailand

Volumn 88, Issue 12, 2005, Pages 1966-1972

  Kirtsreesakul, Virat ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Etiology; Histology; Nasal polyps; Pathogenesis

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; CELL ADHESION MOLECULE; CYTOKINE; EOTAXIN; GLYCOSAMINOGLYCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 5; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; RANTES; SUPERANTIGEN;

ALLERGY; CELL COMPOSITION; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CYSTIC FIBROSIS; DRUG HYPERSENSITIVITY; EOSINOPHIL; GENETIC PREDISPOSITION; HUMAN; INFECTION; INFLAMMATION; ION TRANSPORT; MAST CELL; MYCOSIS; NOSE POLYP; PLASMA CELL; REVIEW; RHINOSINUSITIS; T LYMPHOCYTE ACTIVATION; UPREGULATION; VASOMOTOR DISORDER;

HUMANS; NASAL POLYPS;

EID: 33244475808     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Slavin RG. Nasal polyps and sinusitis. JAMA 1997; 278: 1849-54.
2. Assanasen P, Naclerio RM. Medical and surgical management of nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2001; 9: 27-36.
3. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996; 17: 231-6.
4. Larsen PL, Tos M, Baer S. En block removal of the ethmoid and ostiomeatal complex in cadavers, with a practical application. Rhinology 1994; 32: 62-4.
5. Hellquist HB. Nasal polyps update. Histopathology. Allergy Asthma Proc 1996; 17: 237-42.
6. Mygind N. Nasal polyps. In: Nasal allergy. London: Blackwell Scientific Publication; 1978: 233-8.
7. Larsen K, Tos M. Clinical course of patients with primary nasal polyps. Acta Otolaryngol 1994; 114: 556-9.
8. Lund VJ. Diagnosis and treatment of nasal polyps. BMJ 1995; 311: 1411-4.
9. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000; 85: 209-14.
10. Kirtsreesakul V. Nasal polyps: the relationship to allergy, sinonasal infection and histopathological type. J Med Assoc Thai 2004; 87: 277-82.
11. Jareoncharsri P, Bunnag C, Tunsuriyawrong P, Assanasen P, Muangsomboon S. Clinical and histopathological classification of nasal polyps in Thais. Siriraj Hosp Gaz 2002; 54: 689-97.
12. Stammberger H. Examination and endoscopy of the nose and paranasal sinuses. In: Mygind N, Lildholdt T, editors. Nasal polyposis: an inflammatory disease and its treatment. Coponhagen: Munksgaard; 1997: 120-36.
13. Asero R, Bottazzi G. Nasal polyposis: a study of its association with airborne allergen hypersensitivity. Ann Allergy Asthma Immunol 2001; 86: 283-5.
14. Pumhirun P, Limitlaohapan C, Wasuwat P. Role of allergy in nasal polyps of Thai patients. Asian Pac J Allergy Immunol 1999; 17: 13-5.
15. Bunnag C, Pacharee P, Vipulakom P, Siriyananda C. A study of allergic factor in nasal polyp patients. Ann Allergy 1983; 50: 126-32.
16. Voegels RL, Santoro P, Butugan O, Formigoni LG. Nasal polyposis and allergy: is there a correlation? Am J Rhinol 2001; 15: 9-14.
17. Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol 1996; 116: 160-3.
18. Caplin I, Haynes TJ, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy 1971; 29: 631-4.
19. Settipane GA. Nasal polyps: epidemiology, pathology, immunology and treatment. Am J Rhinol 1987; 1: 119-26.
20. Keith P, Dolovich J. Allergy and nasal polyposis. In: Mygind N, Lildholdt T, editors. Nasal polyposis: an inflammatory disease and its treatment. Coponhagen: Munksgaard; 1997: 68-77.
21. Shatkin JS, Delsupehe KG, Thisted RA, Corey JP. Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis: a meta-analysis. Otolaryngol Head Neck Surg 1994; 111: 553-6.
22. Drake-Lee A. Nasal polyps. In: Kerr AG, editor. Scott Brown's otolaryngology. Oxford: Butterworth Heinemann; 1997: 4/10/1-14.
23. Ogawa H. A possible role of aerodynamic factors in nasal polyp formation. Acta Otolaryngol Suppl 1986; 430: 18-20.
24. Larsen PL, Tos M. Origin and structure of nasal polyps. In: Mygind N, Lildholdt T, editors. Nasal polyposis: an inflammatory disease and its treatment. Coponhagen: Munksgaard; 1997: 17-30.
25. Szceklik A, Nizankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Immunol 2001; 1: 27-33.
26. Gosepath J, Mann WJ. Aspirin intolerance and nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2002; 10: 3-7.
27. Cook PR. The role of aspirin sensitivity and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2002; 10: 213-6.
28. Perez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, Van Cauwenberge P, et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004; 133: 255-60.
29. Mullol J, Femandez-Morata JC, Roca-Ferrer J, Pujols L, Xaubet A, Benitez P, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol 2002; 109: 824-30.
30. Turcios NL. Cystic fibrosis: an overview. J Clin Gastroenterol 2005; 39: 307-17.
31. Henriksson G, Westrin KM, Karpati F, Wikstrom AC, Stierna P, Hjelte L. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest 2002; 121: 40-7.
32. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000; 30: 481-9.
33. Jang YJ, Lee CH. Localization of cystic fibrosis transmembrane conductance regulator in epithelial cells of nasal polyps and postoperative polypoid mucosae. Acta Otolaryngol 2001; 121: 93-7.
34. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
35. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
36. Hess A, Bloch W, Rocker J, Addicks K, Stennert E, Michel O. In vitro expression of inducible nitric oxide synthase in the nasal mucosa of guinea pigs after incubation with lipopolysaccharides or cytokines. Eur Arch Otorhinolaryngol 1998; 255: 448-53.
37. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-45.
38. Karlidag T, Ilhan N, Kaygusuz I, Keles E, Yalcin S, Yildiz M. Role of free radicals, nitric oxide, and scavenging enzymes in nasal polyp development. Ann Otol Rhinol Laryngol 2005; 114: 122-6.
39. Payne DN. Nitric oxide in allergic airway inflammation. Curr Opin Allergy Immunol 2003; 3: 133-7.
40. Norlander T, Fukami M, Westrin KM, Stierna P, Carsloo B. Formation of mucosal polyps in the nasal and maxillary sinus cavities by infection. Otolaryngol Head Neck Surg 1993; 109(3 Pt 1): 522-9.
41. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsoo B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope 1996; 106(2 Pt 1): 196-203.
42. Pawankar R. Nasal polyposis: an update. Curr Opin Allergy Immunol 2003; 3: 1-6.
43. Bernstein JM, Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 39-44.
44. Bachert C, Gevaert P, van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57: 480-7.
45. Wedi B, Wieczorek D, Stunkel T, Breuer K, Kapp A. Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol 2002; 109: 477-84.
46. Bachert C, Gavaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-14.
47. Tripathi A, Conley DB, Grammer LC, Ditto AM, Lowery MM, Seiberling KA, et al. Immunoglobulin E to Staphylococcal and Streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope 2004; 114: 1822-6.
48. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 237-42.
49. Sasama J, Sherris DA, Shin SH, Kephart GM, Kern EB, Ponikau JU. New paradigm for the role of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 2-8.
50. Marple BF, Mabry RL. The role of fungus in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2002; 10: 207-12.
51. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877-84.
52. Asero R, Bottazzi G. Hypersensitivity to molds in patients with nasal polyposis: a clinical study. J Allergy Clin Immunol 2000; 105(1 Pt 1): 186-8.
53. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96: 24-35.
54. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized double clinical trial. J Allergy Clin Immunol 2004; 113: 1122-8.
55. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000; 110(3 Pt 1): 422-5.
56. Luxenberger W, Posch U, Berghold A, Hofmann T, Lang-Loidolt D. HLA patterns in patients with nasal polyposis. Eur Arch Otorhinolaryngol 2000; 257: 137-9.
57. Sanchez-Segura A, Brieva JA, Rodriguez C. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed Th1/Th2 pattern of cytokines. J Allergy Clin Immunol 1998; 102(6 Pt 1): 953-60.
58. Seki H, Otsuka H, Pawankar R. Studies on the function of mast cells infiltrating nasal polyps. Nippon Jibiinkoka Gakkai Kaiho 1992; 95: 1012-21.
59. Drake-Lee AB, Barker TH, Thurley KW. Nasal polyps. Scanning electron microscopy and artifact. J Laryngol Otol 1984; 98: 285-92.
60. Takasaka T, Kaku Y, Hozawa K. Mast cell degranulation in nasal polyps. Acta Otolaryngol Stockh 1986; 430 (Suppl): 39-48.
61. Lildholt T. Position statement on nasal polyps. Rhinology 1994; 32: 126.
62. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99(6 Pt 1): 837-42.
63. Ohno I, Lea R, Finotto S, Marshall J, Denburg J, Dolovich J, et al. Granulocyte/macrophage colonystimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 1991; 5: 505-10.